BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13191601)

  • 21. The effect of tri-ethylene melamine and of tri-ethylene phosphoramide in human neoplastic diseases.
    WRIGHT JC; PRIGOT A; LOGAN M; HILL LM
    Acta Unio Int Contra Cancrum; 1955; 11(2):220-57. PubMed ID: 13248731
    [No Abstract]   [Full Text] [Related]  

  • 22. [Practical results of use of triethylenemelamine in neoplastic diseases. IV. Lung neoplasms].
    LENTI G; GAVOSTO F
    G Ital Chemioter; 1954; 1(1):104-5. PubMed ID: 13191595
    [No Abstract]   [Full Text] [Related]  

  • 23. Triethylene melamine in the management of far advanced ovarian cancer.
    SYKES MP; RUNDLES RW; PIERCE VK; KARNOFSKY DA
    Surg Gynecol Obstet; 1955 Aug; 101(2):133-40. PubMed ID: 14396722
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oral triethylene melamine therapy of malignant lymphogranuloma and related conditions].
    VAN DER HEIDE-WESSEL C; GROEN J
    Ned Tijdschr Geneeskd; 1951 Nov; 95(47):3542. PubMed ID: 14919679
    [No Abstract]   [Full Text] [Related]  

  • 25. [Triethylenemelamine in the treatment for malignant neoplasms: review of the literature and 36 personal cases].
    CLOSON J
    Acta Gastroenterol Belg; 1956 Jul; 19(7):521-42. PubMed ID: 13354235
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of malignant diseases of the blood with cortisone, triethylene melamine and the trace elements].
    DUBOIS-FERRIERE H
    Schweiz Med Wochenschr; 1951 Dec; 81(50):1235-7. PubMed ID: 14913076
    [No Abstract]   [Full Text] [Related]  

  • 27. TRIETHYLENE-MELAMINE.
    Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
    [No Abstract]   [Full Text] [Related]  

  • 28. Triethylene melamine therapy in Hodgkin's and other malignant diseases.
    HANSEN PB; BICHEL J
    Acta radiol; 1951 Dec; 36(6):469-76. PubMed ID: 14902588
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary carcinoma of the liver: report of 20 cases, including two treated with triethylene melamine.
    WILSON HM
    Ann Intern Med; 1954 Jul; 41(1):118-23. PubMed ID: 13171795
    [No Abstract]   [Full Text] [Related]  

  • 30. Further observations on the use of triethylene melamine in neoplastic diseases.
    WRIGHT JC; PRIGOT A; WRIGHT LT; ARONS I
    AMA Arch Intern Med; 1952 Mar; 89(3):387-404. PubMed ID: 14902152
    [No Abstract]   [Full Text] [Related]  

  • 31. Triethylene melamine in the treatment of lymphomas and other neoplastic diseases.
    BURTNER OW; JENSEN LC; RUMBALL JM
    Ann Intern Med; 1953 Jun; 38(6):1222-44. PubMed ID: 13065973
    [No Abstract]   [Full Text] [Related]  

  • 32. [First results of therapy with triethylene melamine].
    NOWOTNA-WALCOWA R
    Pol Tyg Lek (Wars); 1955 Feb; 10(5):149-51. PubMed ID: 14371117
    [No Abstract]   [Full Text] [Related]  

  • 33. [Additional occurrence of carcinoma in a malignant disease treated with triethylene melamine].
    LUHRS W; SCHAMMEL J; LOTZ HH
    Z Gesamte Inn Med; 1954 Mar; 9(6):295-9. PubMed ID: 13170253
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cytotoxic drugs and malignant tumors; action of triethylene melamine, of diethylene-dipropryloxy-benzoquinone and of thiophosphoramide].
    RAVINA A; PESTEL M
    Presse Med (1893); 1958 Mar; 66(17):371-4. PubMed ID: 13542572
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thirty cases of chronic leukemic lymphadenosis treated with intravenous administration of triethylene melamine].
    GIGANTE D; ZOPPINI A
    Prog Med (Napoli); 1956 Jun; 12(12):361-8. PubMed ID: 13350408
    [No Abstract]   [Full Text] [Related]  

  • 36. Hematopoietic depression from nitrogen mustard and triethylene melamine.
    MRAZEK RG; WACHOWSKI TJ
    J Am Med Assoc; 1955 Sep; 159(3):160-3. PubMed ID: 13251857
    [No Abstract]   [Full Text] [Related]  

  • 37. Nasopharyngeal carcinoma. II. Treatment with urethane (ethyl carbamate) and triethylene melamine.
    LAWLEY M; MEKIE DE
    Surg Gynecol Obstet; 1955 Aug; 101(2):141-52. PubMed ID: 14396723
    [No Abstract]   [Full Text] [Related]  

  • 38. Observations on the use of triethylene melamine in Hodgkin's disease.
    DE ANDINO AM; ROMERO C; RIVERA J; RODRIGUEZ-MOLINA R
    Bol Asoc Med P R; 1953 Apr; 45(4):107-18. PubMed ID: 13066528
    [No Abstract]   [Full Text] [Related]  

  • 39. Triethylene melamine therapy in the lymphomatous diseases.
    RUNDLES RW
    South Med J; 1955 Dec; 48(12):1331-4. PubMed ID: 13274172
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical use of triethylene melamine; report of seventy-five cases.
    BOND WH; ROHN RJ; DYKE RW; FOUTS PJ
    AMA Arch Intern Med; 1953 May; 91(5):602-17. PubMed ID: 13039612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.